PubMed:1820196 / 165-312 JSONTXT

{"project":"sentences","denotations":[{"id":"TextSentencer_T3","span":{"begin":0,"end":147},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":147},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":147},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"EPO has recently become available for the treatment of anaemia as the first human recombinant biomedicine produced in heterologous mammalian cells."}

{"project":"ICD10","denotations":[{"id":"T1","span":{"begin":55,"end":62},"obj":"http://purl.bioontology.org/ontology/ICD10/D64.9"}],"text":"EPO has recently become available for the treatment of anaemia as the first human recombinant biomedicine produced in heterologous mammalian cells."}

{"project":"GlycoBiology-FMA","denotations":[{"id":"_T8","span":{"begin":141,"end":146},"obj":"FMAID:68646"},{"id":"_T9","span":{"begin":141,"end":146},"obj":"FMAID:169002"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"EPO has recently become available for the treatment of anaemia as the first human recombinant biomedicine produced in heterologous mammalian cells."}

{"project":"uniprot-human","denotations":[{"id":"T4","span":{"begin":0,"end":3},"obj":"http://www.uniprot.org/uniprot/P01588"},{"id":"T10","span":{"begin":0,"end":3},"obj":"http://www.uniprot.org/uniprot/P11678"}],"text":"EPO has recently become available for the treatment of anaemia as the first human recombinant biomedicine produced in heterologous mammalian cells."}

{"project":"uniprot-mouse","denotations":[{"id":"T4","span":{"begin":0,"end":3},"obj":"http://www.uniprot.org/uniprot/P49290"}],"text":"EPO has recently become available for the treatment of anaemia as the first human recombinant biomedicine produced in heterologous mammalian cells."}

{"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T4","span":{"begin":141,"end":146},"obj":"http://purl.bioontology.org/ontology/STY/T025"}],"text":"EPO has recently become available for the treatment of anaemia as the first human recombinant biomedicine produced in heterologous mammalian cells."}

{"project":"GO-CC","denotations":[{"id":"T2","span":{"begin":141,"end":146},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"EPO has recently become available for the treatment of anaemia as the first human recombinant biomedicine produced in heterologous mammalian cells."}

{"project":"EDAM-topics","denotations":[{"id":"T2","span":{"begin":76,"end":81},"obj":"http://edamontology.org/topic_2815"}],"text":"EPO has recently become available for the treatment of anaemia as the first human recombinant biomedicine produced in heterologous mammalian cells."}

{"project":"mondo_disease","denotations":[{"id":"T1","span":{"begin":55,"end":62},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0002280"}],"text":"EPO has recently become available for the treatment of anaemia as the first human recombinant biomedicine produced in heterologous mammalian cells."}

{"project":"NCBITAXON","denotations":[{"id":"T2","span":{"begin":76,"end":81},"obj":"OrganismTaxon"}],"attributes":[{"id":"A2","pred":"db_id","subj":"T2","obj":"9606"}],"text":"EPO has recently become available for the treatment of anaemia as the first human recombinant biomedicine produced in heterologous mammalian cells."}

{"project":"GlyCosmos15-HP","denotations":[{"id":"T1","span":{"begin":55,"end":62},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0001903"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"EPO has recently become available for the treatment of anaemia as the first human recombinant biomedicine produced in heterologous mammalian cells."}